Figure 3.
Immunohistochemistry of muscle cross-sections to view dystrophin (a–c) and γ-sarcoglycan (d–f). C57 control TA displayed positive staining for both proteins (a and d). Lower staining intensity for dystrophin and γ-sarcoglycan was observed in mdx TAs treated with gentamicin (b and e). No dystrophin staining, and only minimal staining of γ-sarcoglycan, were seen in mdx control TA muscles (c and f). Scale bar: 25 μm.